Dr. R Shrikanth

Dr. Shrikanth Ravichandran is an experienced medical and hemato-oncologist who has a vast experience in management of all solid tumors and blood cancers. Having undergone meticulous training at the prestigious Gujarat Cancer & Research Institute (GCRI) which acts as a regional cancer centre for around 2 million people, he is well versed in the treatment of cancers with chemotherapy with special interest in targeted therapy and immunotherapy. He received his MD in General Medicine from Indira Gandhi Government Medical College and his DM in Medical and hemato-oncology from GCRI. He is European certified medical oncologist (ECMO) having cleared the ESMO examination. He has also received the prestigious MRCP SCE certificate in medical oncology from the Federation of Royal College of physicians of the United Kingdom.

● Isolated CNS relapse in a case of pancreatic plasmablastic lymphoma. Gujarat Cancer Society Research Journal; vol 25; number 2; October 2023. Pg 32-35

● Co PI in clinical trial in GCRI: A multicenter, open-label, randomized, phase III clinical trial to evaluate efficacy and safety of PF-114 versus imatinib at 600 or 800 mg daily in adult patients with Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML) in the chronic phase (CP) resistant to imatinib at daily doses of 400 or 600 mg.